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RESUMO – A infecção cutânea por Mycobacterium haemophilum é uma patologia rara, de difícil diagnóstico e cujo 
tratamento constitui um desafio. Descreve-se o caso de um doente sob corticoterapia crónica no contexto de miosite 
com nódulos dos membros inferiores, nos quais foi detectada uma estirpe de Mycobacterium haemophilum pela téc-
nica de PCR. Este caso enfatiza a necessidade de um alto nível de suspeição clínica para o diagnóstico. De facto, esta 
infecção pode actualmente estar sub-diagnosticada devido aos requisitos especiais de cultura. Deve ser considerada 
em doentes com processos granulomatosos crónicos em associação a exame cultural persistentemente negativo.
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MYCOBACTERIUM HAEMOPHILUM SKIN INFECTION IN AN 
IMMUNOCOMPROMISED PATIENT
ABSTRACT – Mycobacterium haemophilum skin infection is a rare disease with a difficult diagnosis and a challenging 
treatment. We report the case of a patient on chronic corticotherapy for myositis with nodules on the lower limbs in 
which Mycobacterium haemophilum was identified by PCR technique. This case emphasizes the need for a high index 
of suspicion for the diagnosis. In fact, this infection can currently be underdiagnosed due to the special requirements 
for culture. It should be considered in patients with chronic granulomatous processes in combination with negative my-
cobacteriological examination.
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INTRODUCTION
Mycobacterium is a genus that includes several 
species, namely M. tuberculosis, M. leprae and atypical 
mycobateria. Pinner introduced the latter concept in the 
30s and since then it has gained increasing importance 
due to human immunodeficiency virus (HIV) infection 
and the use of immunossuppressors1.
Mycobacterium haemophilum was first described 
in 1978 in a patient with Hodgkin disease2. It causes 
disease in two distinct groups, particularly in immuno-
compromised adults and immunocompetent children3.
CASE REPORT
A 67-year-old male was observed due to hyperpig-
mented macules and violaceous to brown papules and 
nodules (Fig. 1), some of them draining a yellowish 
exudate on the lower limbs, evolving for more than 
a year. The patient denied recent travel history howe-
ver in the past he had traveled to several countries in 
Africa. He suffered from myositis and cardiovascular 
disease and was medicated for several years with 
deflazacort, acenocoumarol, aspirin, amiodarone, 
digoxin, diltiazem, furosemide, omeprazole and 
trazodone. Histological examination revealed granu-
lomatous inflammation with central necrosis (Fig. 2). 
Bacteriological, mycological and mycobacteriological 
examination were negative.
As new lesions were appearing the patient was 
submitted again to skin biopsy. Histology was similar 
to the previous one but this time Ziehl-Neelsen stain 
revealed the presence of acid-fast bacilli exhibiting cord 
formation. Tissue culture was negative for bacteria, 
fungi and mycobacteria. PCR technique was negative 
for M. tuberculosis but detected a strain of M. haemo-
philum. The microbiological examination of respiratory 
secretions was negative and chest X-ray, brain CT and 
brain and spine MRI revealed no significant changes.
The diagnosis of M. haemophilum skin infection 
was made and treatment with rifampicin (600mg/
day), clarithromycin (500mg, 2id) and ciprofloxacin 
(500mg, 2id) was started. However clarithromycin 
was suspended two weeks later due to gastrointestinal 
intolerance. 
At three months of treatment (rifampicin and cipro-
floxacin) a decrease in the number and size of lesions 
was noted but ciprofloxacin was suspended due to 
progressive weight loss and persistent vomiting. Clari-
thromycin was reintroduced, however a week later the 
patient stopped it on his own initiative. The patient con-
tinued only with rifampicin but three months later new 
lesions developed. Swab microbiological culture yielded 
negative results and persistence of M. haemophilum was 
detected by PCR technique. The patient refused reintro-
duction of clarithromycin or ciprofloxacin. 
At six months of treatment with rifampicin the patient 
was admitted to another hospital due to aspiration 
pneumonia with favorable response to antibiotic the-
rapy. One month later he was readmitted and died from 
multiple organ failure.
DISCUSSION
M. haemophilum infection is a rare disease with less 
than 300 cases reported in the literature. Many aspects 
Fig. 1 - Violaceous to brown papules and nodules on the lower limbs (a,b); yellowish exudate during biopsy (c).
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of its epidemiology are still unknown, namely the reser-
voir and the mode of transmission3,4. However an envi-
ronmental source was suggested due to the absence of 
reported cases of person to person transmission and 
variable genetic pattern of isolates in different geogra-
phical areas5.
M. haemophilum is an acid-fast, aerobic, slow 
growing bacilli, with preferential temperatures between 
30-32o C, which explains its predilection for the extre-
mities5. As other atypical mycobacteria usually affects 
immunocompromised adults, although disease in 
immunocompetent children and rarely in immunocom-
petent adults have also been described3,4.
This infection has been reported in patients with 
HIV infection, transplants, hematologic dyscrasias and 
diseases requiring chronic immunosuppressive thera-
pies3,4,6. Cutaneous lesions are the most frequent fin-
ding, although septic arthritis, osteomyelitis, pulmonary 
or disseminated disease may also occur3. Cutaneous 
involvement is characterized by papules, nodules and 
cysts, that often evolve with suppuration and ulceration, 
usually affecting the extremities, followed by the trunk 
and rarely the face3,5. Albeit less frequent M. haemophi-
lum infection has been described in immunocompetent 
adults, namely in association to permanent makeup 
of the eyebrows and cervical lymphadenitis similar to 
children7,8.
On the other hand immunocompetent children 
present with cervical, submandibular or perihilar lym-
phadenopathy. This group has a favorable prognosis 
and the treatment consists in the surgical excision of the 
affected lymph node3,6. Rare cases of M. haemophilum 
infection have been described in immunocompromised 
children with identical clinical manifestations to immu-
nocompromised adults9,10.
Deep fungal infections and other mycobacterial 
infections are the most important differential diagnosis. 
Panniculitis, lymphoma, vasculitis and sarcoidosis are 
other diseases that should be considered. The diagnosis 
is the result from the combination of histopathological 
and microbiological examination.
Histological findings include the presence of granu-
lomatous inflammation with variable foci of necrosis, 
which can be accompanied by neutrophilic or mixed 
cellular infiltrates3,4,6. Granulomas are not always 
evident in immunocompromised patients5. The Ziehel-
-Neelsen staining typically reveals numerous acid-
-resistant bacilli, singly or arranged in cord formation, 
however in our case this bacilli were observed only in 
one of the biopsies5.
Culturing M. haemophilum takes about 3-5 weeks 
and is particularly difficult, as noted in our patient in 
which several attempts were made. This difficulty is due 
to the exigent requirements for growth in culture, such 
as temperature between 30 to 32°C and the need for 
iron supplementation4,5. In this setting PCR technique is 
particularly useful because it allows rapid results and 
earlier onset of treatment which is very important in 
immunosuppressed patients. However culture remains 
the gold standard for diagnosis as it allows the iden-
tification of the agent and the performance of drug 
susceptibility testing.
Clinical presentation and the degree of patient immu-
nossupression are the main determinants of treatment. 
Surgical excision of the affected lymph node is the treat-
ment of choice in immunocompetent children. In immu-
nocopromised patients the reversal of immunosupression 
and antibiotics are the preferred approach11. However in 
our case corticosteroids withdrawal was not possible and 
a multiple antibiotic regimen was performed.
Fig 2 - Granulomatous inflammation with central necrosis (H&E).
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Standard guidelines for the treatment of M. haemo-
philum infection are still missing. Some authors suggest 
combination of multiple antibiotics for long periods (12 
to 24 months)3. In respect to in vitro susceptibility testing 
it was found that the isolates usually exhibit sensitivity to 
macrolides and rifamycins, while the fluoroquinolones, 
streptomycin, clofazimine and amikacin exhibit varia-
ble activity5. Furthermore antibiotics such as isoniazid, 
ethambutol, tetracyclines, cefoxitin, cotrimoxazole and 
pyrazinamide are usually inactive5.
The most commonly used antibiotics belong to the 
group of macrolides, fluoroquinolones and rifamycins. 
Clarithromycin appears to be the most effective drug 
against M. haemophilum5. Multiple drug regimen is 
used to prevent the development of resistances11. In 
fact, cases of resistance to rifamycins are described 
after several months of treatment12. According to Kelley 
et al5, the initial treatment should include clarithromycin 
and a rifamycin, and in cases of severe or disseminated 
disease a fluoroquinolone should be added. This triple 
combination was our initial choice, however the patient 
developed severe gastrointestinal intolerance and sus-
pended clarithromycin.
In addition to the importance of multiple antibiotic 
association to prevent the emergence of resistance, is 
also very important the compliance to treatment11. In 
fact suspicion of poor compliance was a serious pro-
blem in this patient.
Our patient died in another hospital due to multiple 
organ failure, however an autopsy was not performed. 
This procedure could have been useful to assess the 
eventual presence of disseminated disease.
CONCLUSION
Increased life expectancy of patients with HIV infec-
tion and the increasing use of immunosuppressive 
treatments may lead to a raise in M. haemophilum 
infection in the future. On the other hand, this infection 
can currently be underdiagnosed. M. haemophilum is a 
slow-growing nontuberculous mycobacteria with special 
requirements for growth. This infection should always be 
considered in patients with chronic granulomatous pro-
cesses or with numerous acid-fast bacilli in association 
with persistently negative microbiological examination. 
In conclusion, this case emphasizes the need of a high 
index of suspicion of the diagnosis.
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